Recent Drug Approvals

New and Generic Drug Approvals

June 25, 2015

Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type
Amyvid florbetapir f-18 Solution;Intravenous Avid Radiopharms Inc Manufacturing Change or Addition
Banzel rufinamide Tablet;Oral Eisai Inc Labeling Revision
Banzel rufinamide Suspension;Oral Eisai Inc Labeling Revision
Cabazitaxel cabazitaxel Injectable;Injection Accord Hlthcare Inc Tentative Approval
Zuplenz ondansetron Film;Oral Galena Biopharma Inc Manufacturing Change or Addition

For more information go to FDA

Disclaimer: The EDC Developer blog is “one man’s opinion”. Anything that is said on the report is either opinion, criticism, information or commentary. If making any type of investment or legal decision it would be wise to contact or consult a professional before making that decision